Neoadjuvant niraparib in men with DNA repair gene deficient clinically localized prostate cancer: Clinical and molecular results from a phase 2 investigator-initiated trial.

Marc Dall’Era(University of California, Davis), Primo N. Lara(UC Davis Comprehensive Cancer Center), Nicholas Mitsiades(Harvard University), Mamta Parikh(UC Davis Comprehensive Cancer Center), Irene Mitsiades(Harvard University), John D. McPherson(Baylor College of Medicine), Kenneth A. Iczkowski(University of California, Davis)
Journal of Clinical Oncology
May 28, 2025
Cited by 1


Related Papers